-
A newly approved drug can extend the lives of children with progeria, a rare disorder that causes rapid aging. The drug is the result of one family's effort to help a child with the fatal condition.
-
The vaccine was found to be 95% effective in an updated study analysis. Safety data required by the Food and Drug Administration showed no serious concerns, the company said.
-
Eli Lilly's monoclonal antibody will be available to people 65 or older or those with underlying health conditions. Supplies will be short, and allocating the medicine will be a challenge.
-
An NPR investigation revealed a network of doctors marketing a non-FDA approved drug as a purported treatment for COVID-19. Now, Rep. Raja Krishnamoorthi (D-Ill.) is calling for federal enforcement.
-
The pledge comes one month after a survey found that only 2 in 5 Americans said they planned to get vaccinated against COVID-19.
-
The Food and Drug Administration's chief said Sunday the therapy reduces deaths among COVID-19 patients by 35%. On Monday he apologized, acknowledging that statistic greatly exaggerates any benefit.
-
Emergency use authorization makes it easier for doctors to use a drug in a manner not specifically approved by the Food and Drug Administration. The FDA granted these drugs this status in March.
-
These tests are designed to identify people who have been previously exposed to the virus. The Food and Drug Administration is now telling manufacturers they'll have to meet minimum standards.
-
The agency said Friday that using hydroxychloroquine and a related compound, chloroquine, for COVID-19 may cause life-threatening side effects. That warning contradicts the president's own enthusiasm.
-
Federal rules had made such donors wait 12 months before donating. That wait is now three months. The coronavirus outbreak has caused donor centers to be closed and blood drives canceled.